Geneva Glen Capital

Geneva Glen Capital is a Chicago-based private equity firm that invests in lower middle-market companies across various sectors. The firm focuses on companies headquartered in the U.S. or Canada with EBITDA between $3 million and $20 million, targeting investments of $10 to $50 million per transaction. Geneva Glen Capital partners with successful management teams to invest in proven private companies with leading market positions, significant growth potential, and stable cash flows. The firm employs a flexible and creative approach, offering patient and flexible capital to support long-term operational growth. Geneva Glen Capital's principals have extensive private equity experience, collectively bringing over 75 years of investing experience. They work closely with management teams to establish and execute clearly defined value creation and growth plans, emphasizing conservative capital structures and high standards of integrity and reliability. The firm's portfolio includes companies in sectors such as business services, consumer products, healthcare, industrial manufacturing, and insurance services. Geneva Glen Capital's investment philosophy centers on forming lasting partnerships without the inherent conflicts that traditional private equity firms often face, focusing on the best interests of each portfolio company and its management team. This approach allows the firm to be nimble, decisive, and creative, with a closing rate that exceeds industry standards. By investing throughout the capital structure, Geneva Glen Capital provides solutions best meeting the needs of the business, collaborating with management teams to build long-term value and ensuring full alignment of interests with co-investors and senior management teams. The firm's patient capital backing, sourced from family offices and other institutional investors, enables it to focus on both the short- and long-term needs of its portfolio companies, avoiding the inherent conflicts that traditional private equity firms face when making liquidity decisions. This patient capital approach allows Geneva Glen Capital to be far more flexible than a typical private equity firm, with a focus on building long-term value that allows for a more flexible investment horizon. The firm's conservative leverage practices reduce the risk of financial distress in its portfolio companies, allowing management teams to focus on building long-term value rather than worrying about financial covenants. Geneva Glen Capital's commitment to professionalism, flexibility, and patient capital has established it as a trusted partner for lower middle-market companies seeking to realize their full potential. The firm's approach emphasizes collaboration with seasoned industry operating executives, aligning incentives with management through meaningful equity participation, and entrusting management with day-to-day operations without micromanaging. This deep appreciation for company culture and history fosters strong partnerships and supports the growth and success of its portfolio companies. Geneva Glen Capital's values and approach are centered on generating returns by investing in growing companies, rather than employing financial engineering tactics. The firm's funding structure provides the flexibility to ensure full alignment of interests with co-investors and senior management teams, allowing it to focus on both the short- and long-term needs of its portfolio companies. By avoiding the inherent conflicts that traditional private equity firms face when making liquidity decisions, Geneva Glen Capital is able to honor the terms it presents, communicate transparently, and perform to standards of speed and certainty of closing that far exceed industry norms. This commitment to integrity, resourcefulness, and creativity in overcoming obstacles and resolving complex situations has established Geneva Glen Capital as a leading private equity firm in the lower middle-market sector.

Geneva Glen Capital's portfolio includes companies such as Flow Polymers, a manufacturer of chemical dispersions, process aids, and homogenizing agents for pharmaceutical and other markets. The firm's investment in Flow Polymers highlights its focus on companies with leading market positions and significant growth potential. Geneva Glen Capital's approach to investing in lower middle-market companies is characterized by a commitment to professionalism, flexibility, and patient capital, allowing it to be a nimble and decisive partner for management teams seeking to build long-term value. The firm's conservative capital structures and high standards of integrity and reliability have established it as a trusted partner for companies across various sectors, including business services, consumer products, healthcare, industrial manufacturing, and insurance services. Geneva Glen Capital's investment philosophy centers on forming lasting partnerships without the inherent conflicts that traditional private